Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2022TransplantologyOpen Access

Dyslipidemia in Renal Transplant Recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKarolina ChmielnickaZHZbigniew HeleniakADAlicja Dębska‐Ślizień

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chmielnicka et al. (2022) studied this question.

synapsesocial.com/papers/6a813b1cd7cc36764366180bhttps://doi.org/10.3390/transplantology3020020
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New-Onset Diabetes after Kidney Transplantation2021 · 57 citations
  2. 2Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy With Improved Late Survival and Decreased Cardiac Events After Cardiac Transplantation2011 · 112 citations
  3. 3A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)2010 · 952 citations
  4. 4Prevalence and Risk Factors of New-Onset Diabetes After Transplantation (NODAT)2020 · 17 citations